LTGO · Latigo Biotherapeutics, Inc. · Documents
$15.26
+0.24 (+1.60%)
At close · Oct 26
Return incl. dividend (before tax)
Going-concern doubt
— cleared Sep 3, 2026
The latest filing states the doubt was alleviated.
“Accordingly, the prior substantial doubt about the Company's ability to continue as a going concern has been alleviated.”View the 10-Q filed Sep 3, 2026
Market Cap
$954.38M
Shares
66.30M
Volume · Oct 26
165.33K
Avg daily vol (56 sessions)
349.92K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.